| P50 | author | Richard D Schulick | Q91967643 |
| P2093 | author name string | Michael G House | |
| P2860 | cites work | Menin, the product of the MEN1 gene, is a nuclear protein | Q24310070 |
| | Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1 | Q28243243 |
| | Molecular pathology of the MEN1 gene | Q28262579 |
| | Positional cloning of the gene for multiple endocrine neoplasia-type 1 | Q28307577 |
| | Origin of exocrine pancreatic cells from nestin-positive precursors in developing mouse pancreas | Q28584996 |
| | Chairpersons of pathology in the United States. Benchmarks for academic publications and professional credentials | Q30306868 |
| | The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. | Q33889383 |
| | Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis | Q33927967 |
| | Interventional treatment of gastrointestinal neuroendocrine tumours | Q34001708 |
| | Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review | Q34001727 |
| | Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. | Q34810946 |
| | Management of neuroendocrine liver metastases | Q35620908 |
| | Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway | Q35663471 |
| | The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value | Q40511163 |
| | Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract | Q40563679 |
| | Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours | Q44856223 |
| | Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms | Q45077891 |
| | Aberrant Hypermethylation of Tumor Suppressor Genes in Pancreatic Endocrine Neoplasms | Q47615275 |
| | Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. | Q50639178 |
| | Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns. | Q51575179 |
| | Low frequency of p16(INK4a) alterations in insulinomas. | Q52541222 |
| | Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms. | Q54738057 |
| | Hepatic neuroendocrine metastases: does intervention alter outcomes? | Q55033788 |
| | Role of disease-causing genes in sporadic pancreatic endocrine tumors:MEN1andVHL | Q57290138 |
| | Liver transplantation for neuroendocrine tumors | Q57648510 |
| | Classification and histogenesis of gastroenteropancreatic endocrine tumours | Q61852971 |
| | Multiple genetic alterations in malignant metastatic insulinomas | Q70917406 |
| | Results of liver transplantation for gastroenteropancreatic tumor metastases | Q70969271 |
| | Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation | Q71184140 |
| | Hepatic resection for metastatic neuroendocrine carcinomas | Q72400702 |
| | Liver transplantation for metastatic neuroendocrine tumors | Q73256758 |
| | Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas | Q73351512 |
| | Lack of MEN1 gene mutations in 27 sporadic insulinomas | Q73664319 |
| | Liver metastases arising from well-differentiated pancreatic endocrine neoplasms demonstrate increased VEGF-C expression | Q73670277 |
| | Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? | Q74770146 |
| | MAGE1 is expressed by a subset of pancreatic endocrine neoplasms and associated lymph node and liver metastases | Q75236483 |
| | Loss of p27 Nuclear Expression in a Prognostically Favorable Subset of Well-Differentiated Pancreatic Endocrine Neoplasms | Q79276760 |
| | Aggressive surgery for metastatic liver neuroendocrine tumors | Q79359618 |
| P433 | issue | 1 | |
| P921 | main subject | pancreas | Q9618 |
| P304 | page(s) | 23-29 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Current Opinion in Oncology | Q1909046 |
| P1476 | title | Endocrine tumors of the pancreas. | |
| P478 | volume | 18 | |